Our study presents a validated nomogram incorporating 4 key predictors-gender, SDH thickness, SDH density, and pontomesencephalic angle-that accurately estimates treatment failure risk following an EBP in patients with SIH and a concurrent SDH. This tool offers practical value for individualized risk assessment and clinical decision-making.
Huang et al. (Thu,) studied this question.